Do Nonhuman Primate or Bat Adenoviruses Pose a Risk for Human Health?

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

This work was supported by grants from the European Commission through the 7th Framework Programs: ADVance (#290002) to M Benkő, B Harrach and EJ Kremer; and BrainCAV (#222992) to EJ Kremer. This work was also supported by the Region Languedoc Roussillon, the Fondation de France, Vaincre les Maladies Lysosomales, Agence National de la Recherche and the Association Française contre les Myopathies to EJ Kremer; and grant OTKA NN107632 provided by Hungarian Scientific Research Fund to B Harrach and M Benk. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was used in the production of this manuscript.

Additional information

Funding

This work was supported by grants from the European Commission through the 7th Framework Programs: ADVance (#290002) to M Benkő, B Harrach and EJ Kremer; and BrainCAV (#222992) to EJ Kremer. This work was also supported by the Region Languedoc Roussillon, the Fondation de France, Vaincre les Maladies Lysosomales, Agence National de la Recherche and the Association Française contre les Myopathies to EJ Kremer; and grant OTKA NN107632 provided by Hungarian Scientific Research Fund to B Harrach and M Benk. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was used in the production of this manuscript.